DMD Therapeutics Inc. — Form D
DMD Therapeutics Inc. of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-11. The offering totals $600K. Industry: Other.
Offering
- Filed: 2016-08-11
- Form: D
- Accession: 0001681820-16-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $600K
- Remaining: $600K
- Minimum investment: $100K
- Investors: 3
- Date of first sale: 2016-07-26
- Revenue range: Decline to Disclose
- SEC file number: 021-268698
Issuer
- Name: DMD Therapeutics Inc.
- CIK: 0001681820
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 2032 41st Avenue E, Seattle, WA, 98112
- Phone: 2067901094
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Ronald Berenson | Director | Seattle, WA |
| Ronald Berenson | Executive Officer | Seattle, WA |
| Ronald Berenson | Promoter | Seattle, WA |
More